|
Abhyankar S. Gilliland DG. Ferrara JL. Interleukin-1 is a critical effector molecule during cytokine dysregulation in graft versus host disease to minor histocompatibility antigens. Transplantation. 56(6):1518-23, 1993 2. Akioka K. Nakajima H. Fujiwara I. Mastuda T. Arakawa K. Oka T. Role of natural killer cells in lethal graft-versus-host disease in rat models. Transplantation Proceedings. 29(1-2):722-4, 1997 3. Alessandrino EP. Bernasconi P. Colombo A. Boni M. Bonfichi M. Caldera D. Bernasconi C. Levels of soluble low affinity IL2 receptors (s-IL2 R) and TNF in the serum after BMT. Bone Marrow Transplantation. 7 Suppl 2:51, 1991 4. Anasetti C. Martin PJ. Storb R. Appelbaum FR. Beatty PG. Davis J. Doney K. Hill HF. Stewart P. Sullivan KM. et al. Treatment of acute graft-versus-host disease with a nonmitogenic anti-CD3 monoclonal antibody. Transplantation. 54(5):844-51, 1992 5. Anonymous. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. The U.S. Multicenter FK506 Liver Study Group. New England Journal of Medicine. 331(17):1110-5, 1994 6. Anonymous. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group. Lancet. 344(8920):423-8, 1994 7. Antin JH. Ferrara JL. Cytokine dysregulation and acute graft-versus-host disease. Blood. 80(12):2964-8, 1992 8. Aractingi S. Chosidow O. Cutaneous graft-versus-host disease. Archives of Dermatology. 134(5):602-12, 1998 9. Arai K. Hotokebuchi T. Miyahara H. Arita C. Mohtai M. Sugioka Y. Kaibara N. Limb allografts in rats immunosuppressed with FK506. I. Reversal of rejection and indefinite survival. Transplantation. 48(5):782-6, 1989 10. Arend WP. Interleukin-1 receptor antagonist. Advances in Immunology. 54:167-227, 1993 11. Asai O. Longo DL. Tian ZG. Hornung RL. Taub DD. Ruscetti FW. Murphy WJ. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. Journal of Clinical Investigation. 101(9):1835-42, 1998 12. Atkinson K. Bryant D. Biggs J. Concannon A. Dodds A. Obstructive airways disease: a rare but serious manifestation of chronic graft-versus-host disease, after allogeneic marrow transplantation in humans. Transplantation Proceedings. 16(4):1030-3, 1984 13. Atkinson K. Chronic graft-versus-host disease. Bone Marrow Transplantation. 5(2):69-82, 1990 14. Atkinson K. Horowitz MM. Gale RP. van Bekkum DW. Gluckman E. Good RA. Jacobsen N. Kolb HJ. Rimm AA. Ringden O. et al. Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood. 75(12):2459-64, 1990 15. Bacigalupo A. Frassoni F. van Lint MT. Raffo MR. Vitale V. Corbetta G. Chierichetti S. Marmont AM. Cyclosporin A in marrow transplantation for leukemia and aplastic anemia. Experimental Hematology. 13(4):244-8, 1985 16. Beatty PG. Anasetti C. Hansen JA. Longton GM. Sanders JE. Martin PJ. Mickelson EM. Choo SY. Petersdorf EW. Pepe MS. et al. Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus. Blood. 81(1):249-53, 1993 17. Belanger C. Esperou-Bourdeau H. Bordigoni P. Jouet JP. Souillet G. Milpied N. Troussard X. Kuentz M. Herve P. Reiffers J. et al. Use of an anti-interleukin-2 receptor monoclonal antibody for GVHD prophylaxis in unrelated donor BMT. Bone Marrow Transplantation. 11(4):293-7, 1993 18. Beschorner WE. Namnoum JD. Hess AD. Immunopathology of rat thymus after cyclosporine A. Transplantation Proceedings. 19(1 Pt 2):1230-5, 1987 19. Beschorner WE. Pino J. Boitnott JK. Tutschka PJ. Santos GW. Pathology of the liver with bone marrow transplantation. Effects of busulfan, carmustine, acute graft-versus-host disease, and cytomegalovirus infection. American Journal of Pathology. 99(2):369-85, 1980 20. Beschorner WE. Saral R. Hutchins GM. Tutschka PJ. Santos GW. Lymphocytic bronchitis associated with graft-versus-host disease in recipients of bone-marrow transplants. New England Journal of Medicine. 299(19):1030-6, 1978 21. Beschorner WE. Shinn CA. Hess AD. Suresch DL. Santos GW. Immune-related injury to endothelium associated with acute graft-versus-host disease in the rat. Transplantation Proceedings. 21(1 Pt 3):3025-7, 1989 22. Billingham R. The biology of graft versus host reactions. Harvey Lect. 62:21-73, 1966 23. Billingham RE. Reactions of grafts against their hosts. Science. 130:947-953, 1959 24. Billingham RE. The biology of graft-versus-host reactions. Harvey Lectures. 62:21-78, 1966-67 25. Bortin MM. Rimm AA. Treatment of 144 patients with severe aplastic anemia using immunosuppression and allogeneic marrow transplantation: a report from the international bone marrow transplant registry. Transplantation Proceedings. 13(1 Pt 1):227-9, 1981 26. Buttemeyer R. Jones NF. Min Z. Rao U. Rejection of the component tissues of limb allografts in rats immunosuppressed with FK-506 and cyclosporine. Plastic & Reconstructive Surgery. 97(1):139-48; discussion 149-51, 1996 27. Byers VS. Henslee PJ. Kernan NA. Blazar BR. Gingrich R. Phillips GL. LeMaistre CF. Gilliland G. Antin JH. Martin P. et al. Use of an anti-pan T-lymphocyte ricin a chain immunotoxin in steroid-resistant acute graft-versus-host disease. Blood. 75(7):1426-32, 1990 28. Damoiseaux JG. Dopp EA. Calame W. Chao D. MacPherson GG. Dijkstra CD. Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. Immunology. 83(1):140-7, 1994 29. Davey RJ. Transfusion-associated graft-versus-host disease and the irradiation of blood components. Immunological Investigations. 24(1-2):431-4, 1995 30. De Wit D. Van Mechelen M. Zanin C. Doutrelepont JM. Velu T. Gerard C. Abramowicz D. Scheerlinck JP. De Baetselier P. Urbain J. et al. Preferential activation of Th2 cells in chronic graft-versus-host reaction. Journal of Immunology. 150(2):361-6, 1993 31. Deeg HJ. Graft-versus-host disease: host and donor views. Seminars in Hematology. 30(4 Suppl 4):110-7; discussion 118, 1993 32. Deltz E. Muller-Hermelink HK. Ulrichs K. Thiede A. Muller-Ruchholtz W. Development of graft-versus-host reaction in various target organs after small intestine transplantation. Transplantation Proceedings. 13(1 Pt 2):1215-6, 1981 33. Deltz E. Ulrichs K. Schack T. Friedrichs B. Muller-Ruchholtz W. Muller-Hermelink HK. Thiede A. Graft-versus-host reaction in small bowel transplantation and possibilities for its circumvention. American Journal of Surgery. 151(3):379-86, 1986 34. Dickinson AM. Sviland L. Dunn J. Carey P. Proctor SJ. Demonstration of direct involvement of cytokines in graft-versus-host reactions using an in vitro human skin explant model. Bone Marrow Transplantation. 7(3):209-16, 1991 35. Dijkstra CD. Dopp EA. Joling P. Kraal G. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology. 54(3):589-99, 1985 36. Duquesnoy RJ. Is histocompatibility testing needed for composite tissue transplantation?. Transplantation Proceedings. 30(6):2724-8, 1998 37. Ellison CA. HayGlass KT. Fischer JM. Rector ES. MacDonald GC. Gartner JG. Depletion of natural killer cells from the graft reduces interferon-gamma levels and lipopolysaccharide-induced tumor necrosis factor-alpha release in F1 hybrid mice with acute graft-versus-host disease. Transplantation. 66(3):284-94, 1998 38. Exner BG. Acholonu I. Ildstad ST. Hematopoietic chimerism, tolerance induction and graft-versus-host disease: considerations for composite tissue transfer. Transplantation Proceedings. 30(6):2718-20, 1998 39. Facon T. Janin A. Noel MP. Jouet JP. Involvement of macrophages in lethal forms of graft-versus-host disease. Lancet. 345(8946):392, 1995 40. Ferrara JL. Abhyankar S. Gilliland DG. Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1. Transplantation Proceedings. 25(1 Pt 2):1216-7, 1993 41. Ferrara JL. Cooke KR. Pan L. Krenger W. The immunopathophysiology of acute graft-versus-host-disease. Stem Cells. 14(5):473-89, 1996 42. Ferrara JL. Cytokine dysregulation as a mechanism of graft versus host disease. Current Opinion in Immunology. 5(5):794-9, 1993 43. Ferrara JL. Guillen FJ. van Dijken PJ. Marion A. Murphy GF. Burakoff SJ. Evidence that large granular lymphocytes of donor origin mediate acute graft-versus-host disease. Transplantation. 47(1):50-4, 1989 44. Fritz WD. Swartz WM. Rose S. Futrell JW. Klein E. Limb allografts in rats immunosuppressed with cyclosporin A. Annals of Surgery. 199(2):211-5, 1984 45. Fujioka M. Tanaka S. Uda K. Makabe M. Orita T. Orita K. Inhibition of natural killer (NK) cell prevents graft-vs-host-disease after small bowel transplantation in rats. Transplantation Proceedings. 24(4):1507-8, 1992 46. Fujiwara K. Peszkowski MJ. Larsson A. Yamasaki A. Toda S. Watanabe T. Mononuclear cell thyroiditis in rats with graft-versus-host disease. Journal of Pathology. 175(3):349-55, 1995 47. Gale RP. Bortin MM. van Bekkum DW. Biggs JC. Dicke KA. Gluckman E. Good RA. Hoffmann RG. Kay HE. Kersey JH. et al. Risk factors for acute graft-versus-host disease. British Journal of Haematology. 67(4):397-406, 1987 48. Ghayur T. Seemayer TA. Kongshavn PA. Gartner JG. Lapp WS. Graft-versus-host reactions in the beige mouse. An investigation of the role of host and donor natural killer cells in the pathogenesis of graft-versus-host disease. Transplantation. 44(2):261-7, 1987 49. Ghayur T. Seemayer TA. Lapp WS. Association between the degree of thymic dysplasia and the kinetics of thymic NK cell activity during the graft-versus-host reaction. Clinical Immunology & Immunopathology. 48(1):19-30, 1988 50. Ghayur T. Seemayer TA. Lapp WS. Kinetics of natural killer cell cytotoxicity during the graft-versus-host reaction. Relationship between natural killer cell activity, T and B cell activity, and development of histopathological alterations. Transplantation. 44(2):254-60, 1987 51. Glazier A. Tutschka PJ. Farmer ER. Santos GW. Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution. Journal of Experimental Medicine. 158(1):1-8, 1983 52. Gleichmann E. Pala ST. Rolink AG. Radaszkiewicz T. Gleichmann H. Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological disease. Immunology Today. 5(11):324-32, 1984. 53. Gluckman E. Devergie A. Sohier J. Saurat JH. Graft-versus-host disease in recipients of syngeneic bone marrow. Lancet. 1(8162):253-4, 1980 54. Glucksberg H. Storb R. Fefer A. Buckner CD. Neiman PE. Clift RA. Lerner KG. Thomas ED. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 18(4):295-304, 1974 55. Grant D. Zhong R. Gunn H. Duff J. Garcia B. Keown P. Wijsman J. Stiller C. Graft-versus-host disease associated with intestinal transplantation in the rat. Host immune function and general histology. Transplantation. 48(4):545-9, 1989 56. Grazia Cifone M. Roncaioli P. Cironi L. Festuccia C. Meccia A. D''Alo S. Botti D. Santoni A. NKR-P1A stimulation of arachidonate-generating enzymes in rat NK cells is associated with granule release and cytotoxic activity. Journal of Immunology. 159(1):309-17, 1997 57. Greenbaum BH. Transfusion-associated graft-versus-host disease: historical perspectives, incidence, and current use of irradiated blood products. Journal of Clinical Oncology. 9(10):1889-902, 1991 58. Guillen FJ. Ferrara J. Hancock WW. Messadi D. Fonferko E. Burakoff SJ. Murphy GF. Acute cutaneous graft-versus-host disease to minor histocompatibility antigens in a murine model. Evidence that large granular lymphocytes are effector cells in the immune response. Laboratory Investigation. 55(1):35-42, 1986 59. Hale G. Waldmann H. Recent results using CAMPATH-1 antibodies to control GVHD and graft rejection. Bone Marrow Transplantation. 17(3):305-8, 1996 60. Hebart H. Ehninger G. Schmidt H. Berner B. Reuss-Borst M. Waller HD. Muller CA. Einsele H. Treatment of steroid-resistant graft-versus-host disease after allogeneic bone marrow transplantation with anti-CD3/TCR monoclonal antibodies. Bone Marrow Transplantation. 15(6):891-4, 1995 61. Hemler ME. Adhesive protein receptors on hematopoietic cells. Immunology Today. 9(4):109-13, 1988 62. Herve P. Racadot E. Wijdenes J. Flesch M. Tiberghien P. Bordigoni P. Holler E. Powles M. Bourdeau M. Wilmer E. et al. Monoclonal anti TNF alpha antibody in the treatment of acute GvHD refractory both to corticosteroids and anti IL-2 R antibody. Bone Marrow Transplantation. 7 Suppl 2:149, 1991 63. Hess AD. Jones RC. Santos GW. Autologous graft-vs-host disease: mechanisms and potential therapeutic effect. Bone Marrow Transplantation. 12 Suppl 3:S65-9, 1993 64. Hewitt CW. Black KS. Dowdy SF. Gonzalez GA. Achauer BM. Martin DC. Furnas DW. Howard EB. Composite tissue (limb) allografts in rats. III. Development of donor-host lymphoid chimeras in long-term survivors. Transplantation. 41(1):39-43, 1986 65. Hewitt CW. Black KS. Fraser LA. Howard EB. Martin DC. Achauer BM. Furnas DW. Composite tissue (limb) allografts in rats. I. Dose-dependent increase in survival with cyclosporine. Transplantation. 39(4):360-4, 1985 66. Hewitt CW. Black KS. Henson LE. Achauer BM. Nguyen JH. Lymphocyte chimerism in a full allogeneic composite tissue (rat-limb) allograft model prolonged with cyclosporine. Transplantation Proceedings. 20(2 Suppl 2):272-8, 1988 67. Hewitt CW. Ramsamooj R. Patel MP. Yazdi B. Achauer BM. Black KS. Development of stable mixed T cell chimerism and transplantation tolerance without immune modulation in recipients of vascularized bone marrow allografts. Transplantation. 50(5):766-72, 1990 68. Hewitt CW. Update and outline of the experimental problems facing clinical composite tissue transplantation. Transplantation Proceedings. 30(6):2704-7, 1998 69. Hings IM. Filipovich AH. Miller WJ. Blazar BL. McGlave PB. Ramsay NK. Kersey JH. Weisdorf DJ. Prednisone therapy for acute graft-versus-host disease: short- versus long-term treatment. A prospective randomized trial. Transplantation. 56(3):577-80, 1993 70. Hohnke C. Russavage JM. Subbotin V. Llull R. Starzl TE. Sotereanos GC. Vascularized composite tissue mandibular transplantation in dogs. Transplantation Proceedings. 29(1-2):995, 1997 71. Holland HK. Wingard JR. Beschorner WE. Saral R. Santos GW. Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-v-host disease and low serum IgG. Blood. 72(2):621-7, 1988 72. Holler E. Kolb HJ. Hintermeier-Knabe R. Mittermuller J. Thierfelder S. Kaul M. Wilmanns W. Role of tumor necrosis factor alpha in acute graft-versus-host disease and complications following allogeneic bone marrow transplantation. Transplantation Proceedings. 25(1 Pt 2):1234-6, 1993 73. Hood AF. Vogelsang GB. Black LP. Farmer ER. Santos GW. Acute graft-vs-host disease. Development following autologous and syngeneic bone marrow transplantation. Archives of Dermatology. 123(6):745-50, 1987 74. Hotokebuchi T. Arai K. Takagishi K. Arita C. Sugioka Y. Kaibara N. Limb allografts in rats immunosuppressed with cyclosporine: as a whole-joint allograft. Plastic & Reconstructive Surgery. 83(6):1027-36; discussion 1037-8, 1989 75. Hymes SR. Farmer ER. Lewis PG. Tutschka PJ. Santos GW. Cutaneous graft-versus-host reaction: prognostic features seen by light microscopy. Journal of the American Academy of Dermatology. 12(3):468-74, 1985 76. Ingham Clark CL. Smith G. Lear PA. Crane PW. Wood RF. Fabre JW. Ex vivo depletion of graft T lymphocytes in small intestinal transplantation. Transplantation Proceedings. 23(1 Pt 1):684, 1991 77. Ito S. Ueno M. Nishi S. Arakawa M. Fujiwara M. Suppression of spontaneous murine lupus by inducing graft-versus-host reaction with CD8+ cells. Clinical & Experimental Immunology. 90(2):260-5, 1992 78. Jadus MR. Wepsic HT. The role of cytokines in graft-versus-host reactions and disease. Bone Marrow Transplantation. 10(1):1-14, 1992 79. Kernan NA. Byers V. Scannon PJ. Mischak RP. Brochstein J. Flomenberg N. Dupont B. O''Reilly RJ. Treatment of steroid-resistant acute graft-vs-host disease by in vivo administration of an anti-T-cell ricin A chain immunotoxin. JAMA. 259(21):3154-7, 1988 80. Kernan NA. Collins NH. Juliano L. Cartagena T. Dupont B. O''Reilly RJ. Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease. Blood. 68(3):770-3, 1986 81. Kobayashi E. Kamada N. Enosawa S. Toyama N. Delriviere L. Goto S. Kim YI. Miyata M. Comparison of potentiality to induce graft-versus-host reaction with small bowel, pancreas/spleen, and liver transplantation in the rat. Clinical & Experimental Immunology. 92(3):527-31, 1993 82. Koehler M. Hurwitz CA. Krance RA. Coustan-Smith E. Williams LL. Santana V. Ribeiro RC. Brenner MK. Heslop HE. XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors. Bone Marrow Transplantation. 13(5):571-5, 1994 83. Koehler MT. Howrie D. Mirro J. Neudorf S. Blatt J. Corey S. Wollman M. Kelly-Ekeroth V. Reyes J. FK506 (tacrolimus) in the treatment of steroid-resistant acute graft-versus-host disease in children undergoing bone marrow transplantation. Bone Marrow Transplantation. 15(6):895-9, 1995 84. Kolb H. Sale GE. Lerner KG. Storb R. Thomas ED. Pathology of acute graft-versus-host disease in the dog. An autopsy study of ninety-five dogs. American Journal of Pathology. 96(2):581-94, 1979 85. Lasky LC. Van Buren N. Weisdorf DJ. Filipovich A. McGlave P. Kersey JH. McCullough J. Ramsay NK. Blazar BR. Successful allogeneic cryopreserved marrow transplantation. Transfusion. 29(2):182-4, 1989 86. Lazarus HM. Vogelsang GB. Rowe JM. Prevention and treatment of acute graft-versus-host disease: the old and the new. A report from the Eastern Cooperative Oncology Group (ECOG). Bone Marrow Transplantation. 19(6):577-600, 1997 87. Leitman SF. Holland PV. Irradiation of blood products. Indications and guidelines. Transfusion. 25(4):293-303, 1985 88. Leskinen R. Volin L. Taskinen E. Ruutu T. Renkonen R. Hayry P. Monitoring of bone marrow transplant recipient liver by fine-needle aspiration biopsy. Transplantation. 48(6):969-74, 1989 89. Llull R. Murase N. Demetris AJ. Ye Q. Manez R. Starzl TE. Multilineage amplification of graft-vs-host disease-resistant chimerism following rat vascularized bone marrow allotransplantation. Transplantation Proceedings. 27(4):2363-4, 1995 90. Llull R. Murase N. Ye Q. Demetris AJ. Starzl TE. Chimerism, graft-vs-host disease, rejection, and their association with reciprocal donor-host immune reactions after cell, organ, and composite tissue transplantation. Transplantation Proceedings. 29(1-2):1203-4, 1997 91. Llull R. Murase N. Ye Q. Manez R. Demetris AJ. Fournier V. Starzl TE. Vascularized bone marrow transplantation in rats: evidence for amplification of hematolymphoid chimerism and freedom from graft-versus-host reaction. Transplantation Proceedings. 27(1):164-5, 1995 92. Lui LT. Lai YC. Yeh LS. Hou SM. Jeng CR. Gregory CR. Irradiation or temporal variations in immunosuppressive schedules do not prevent graft-versus-host disease following rat limb allotransplantation. Transplantation Proceedings. 30(8):3960-1, 1998 93. Lukomska B. Durlik M. Cybulska E. Olszewski WL. Reconstitution of lymphoid tissue after vascularized bone marrow transplantation. Annals of Transplantation. 1(1):67-9, 1996 94. Martin P. Nash R. Sanders J. Leisenring W. Anasetti C. Deeg HJ. Storb R. Appelbaum F. Reproducibility in retrospective grading of acute graft-versus-host disease after allogeneic marrow transplantation. Bone Marrow Transplantation. 21(3):273-9, 1998 95. Martin PJ. Hansen JA. Torok-Storb B. Durnam D. Przepiorka D. O''Quigley J. Sanders J. Sullivan KM. Witherspoon RP. Deeg HJ. et al. Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants. Bone Marrow Transplantation. 3(5):445-56, 1988 96. Martin PJ. Nelson BJ. Appelbaum FR. Anasetti C. Deeg HJ. Hansen JA. McDonald GB. Nash RA. Sullivan KM. Witherspoon RP. Scannon PJ. Friedmann N. Storb R. Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantation. Blood. 88(3):824-30, 1996 97. Mason DW. Dallman M. Barclay AN. Graft-versus-host disease induces expression of Ia antigen in rat epidermal cells and gut epithelium. Nature. 293(5828):150-1, 1981 98. Maung ZT. Wood AC. Jackson GH. Turner GE. Appleton AL. Hamilton PJ. Transfusion-associated graft-versus-host disease in fludarabine-treated B-chronic lymphocytic leukaemia. British Journal of Haematology. 88(3):649-52, 1994 99. McCarthy PL Jr. Abhyankar S. Neben S. Newman G. Sieff C. Thompson RC. Burakoff SJ. Ferrara JL. Inhibition of interleukin-1 by an interleukin-1 receptor antagonist prevents graft-versus-host disease. Blood. 78(8):1915-8, 1991 100. McGregor DD. Bone marrow origin of immunologically competent lymphocytes in the rat. Journal of Experimental Medicine. 127(5):953-66, 1968 101. Monchik GJ. Russell PS. Transplantation of small bowel in the rat: technical and immunological considerations. Surgery. 70(5):693-702, 1971 102. Moser M. Sharrow SO. Shearer GM. Role of L3T4+ and Lyt-2+ donor cells in graft-versus-host immune deficiency induced across a class I, class II, or whole H-2 difference. Journal of Immunology. 140(8):2600-8, 1988 103. Muller-Hermelink HK. Sale GE. Borisch B. Storb R. Pathology of the thymus after allogeneic bone marrow transplantation in man. A histologic immunohistochemical study of 36 patients. American Journal of Pathology. 129(2):242-56, 1987 104. Murase N. Demetris AJ. Woo J. Tanabe M. Furuya T. Todo S. Starzl TE. Graft-versus-host disease after brown Norway-to-Lewis and Lewis-to-Brown Norway rat intestinal transplantation under FK506. Transplantation. 55(1):1-7, 1993 105. Murase N. Starzl TE. Tanabe M. Fujisaki S. Miyazawa H. Ye Q. Delaney CP. Fung JJ. Demetris AJ. Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation. 60(2):158-71, 1995 106. Murphy WJ. Longo DL. The potential role of NK cells in the separation of graft-versus-tumor effects from graft-versus-host disease after allogeneic bone marrow transplantation. Immunological Reviews. 157:167-76, 1997 107. Neiman PE. Reeves W. Ray G. Flournoy N. Lerner KG. Sale GE. Thomas ED. A prospective analysis interstitial pneumonia and opportunistic viral infection among recipients of allogeneic bone marrow grafts. Journal of Infectious Diseases. 136(6):754-67, 1977 108. Nestel FP. Price KS. Seemayer TA. Lapp WS. Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease. Journal of Experimental Medicine. 175(2):405-13, 1992 109. Nestel FP. Price KS. Seemayer TA. Lapp WS. Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease. Journal of Experimental Medicine. 175(2):405-13, 1992 110. Niederwieser D. Herold M. Woloszczuk W. Aulitzky W. Meister B. Tilg H. Gastl G. Bowden R. Huber C. Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messages. Transplantation. 50(4):620-5, 1990 111. Nissen C. Gratwohl A. Tichelli A. Speck B. Abundant macrophage growth in culture from patients with chronic myelogenous leukemia: a risk factor for graft-versus-host disease after bone marrow transplantation. Experientia. 44(2):167-9, 1988 112. Parkman R. Graft-versus-host disease. Annual Review of Medicine. 42:189-97, 1991 113. Phillips GL. Nevill TJ. Spinelli JJ. Nantel SH. Klingemann HG. Barnett MJ. Shepherd JD. Chan KW. Meharchand JM. Sutherland HJ. et al. Prophylaxis for acute graft-versus-host disease following unrelated donor bone marrow transplantation. Bone Marrow Transplantation. 15(2):213-9, 1995 114. Piguet PF. Grau GE. Collart MA. Vassalli P. Kapanci Y. Pneumopathies of the graft-versus-host reaction. Alveolitis associated with an increased level of tumor necrosis factor mRNA and chronic interstitial pneumonitis. Laboratory Investigation. 61(1):37-45, 1989 115. Piguet PF. Grau GE. Vassalli P. Subcutaneous perfusion of tumor necrosis factor induces local proliferation of fibroblasts, capillaries, and epidermal cells, or massive tissue necrosis. American Journal of Pathology. 136(1):103-10, 1990 116. Pritchard TJ. Kirkman RL. Small bowel transplantation. World Journal of Surgery. 9(6):860-7, 1985 117. Przepiorka D. Chan KW. Champlin RE. Culbert SJ. Petropoulos D. Ippoliti C. Khouri I. Huh YO. Vreisendorp H. Deisseroth AB. et al. Prevention of graft-versus-host disease with anti-CD5 ricin A chain immunotoxin after CD3-depleted HLA-nonidentical marrow transplantation in pediatric leukemia patients. Bone Marrow Transplantation. 16(6):737-41, 1995 118. Przepiorka D. Weisdorf D. Martin P. Klingemann HG. Beatty P. Hows J. Thomas ED. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplantation. 15(6):825-8, 1995 119. Queen C. Schneider WP. Selick HE. Payne PW. Landolfi NF. Duncan JF. Avdalovic NM. Levitt M. Junghans RP. Waldmann TA. A humanized antibody that binds to the interleukin 2 receptor. Proceedings of the National Academy of Sciences of the United States of America. 86(24):10029-33, 1989 120. Ralph DD. Springmeyer SC. Sullivan KM. Hackman RC. Storb R. Thomas ED. Rapidly progressive air-flow obstruction in marrow transplant recipients. Possible association between obliterative bronchiolitis and chronic graft-versus-host disease. American Review of Respiratory Disease. 129(4):641-4, 1984 121. Ramsamooj R. Llull R. Tatem LD. Black KS. Lotano V. Dalsey RM. Born CT. DeLong WG. Hewitt CW. Graft-versus-host disease in limb transplantation: digital image analysis of bone marrow and TGF-beta expression in situ using a novel 3-D microscope. Transplantation Proceedings. 28(4):2029-31, 1996 122. Reinherz EL. Geha R. Rappeport JM. Wilson M. Penta AC. Hussey RE. Fitzgerald KA. Daley JF. Levine H. Rosen FS. Schlossman SF. Reconstitution after transplantation with T-lymphocyte-depleted HLA haplotype-mismatched bone marrow for severe combined immunodeficiency. Proceedings of the National Academy of Sciences of the United States of America. 79(19):6047-51, 1982 123. Robinet E. Ibrahim A. Truneh A. Ostronoff M. Mishal Z. Zambon E. Gay F. Hayat M. Pico JL. Chouaib S. Serum levels and receptor expression of tumor necrosis factor-alpha following human allogeneic and autologous bone marrow transplantation. Transplantation. 53(3):574-9, 1992 124. Roca J. Granena A. Rodriguez-Roisin R. Alvarez P. Agusti-Vidal A. Rozman C. Fatal airway disease in an adult with chronic graft-versus-host disease. Thorax. 37(1):77-8, 1982 125. Rolink AG. Gleichmann E. Allosuppressor- and allohelper-T cells in acute and chronic graft-vs.-host (GVH) disease. III. Different Lyt subsets of donor T cells induce different pathological syndromes. Journal of Experimental Medicine. 158(2):546-58, 1983 126. Rolink AG. Gleichmann H. Gleichmann E. Diseases caused by reactions of T lymphocytes to incompatible structures of the major histocompatibility complex. VII. Immune-complex glomerulonephritis. Journal of Immunology. 130(1):209-15, 1983 127. Rolink AG. Pals ST. Gleichmann E. Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A. Journal of Experimental Medicine. 157(2):755-71, 1983 128. Rowlings PA. Przepiorka D. Klein JP. Gale RP. Passweg JR. Henslee-Downey PJ. Cahn JY. Calderwood S. Gratwohl A. Socie G. Abecasis MM. Sobocinski KA. Zhang MJ. Horowitz MM. IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. British Journal of Haematology. 97(4):855-64, 1997 129. Roy C. Ghayur T. Kongshavn PA. Lapp WS. Natural killer activity by spleen, lymph node, and thymus cells during the graft-versus-host reaction. Transplantation. 34(3):144-6, 1982 130. Sahin S. Akoglu TF. Gurbuz O. Ergun T. Kullu S. Sav A. Ahiskali R. Tuzuner N. Dogusoy G. Re-evaluation of skin-explant model in graft-versus-host disease prediction. Clinical Transplantation. 9(5):370-4, 1995 131. Saitoh T. Fujiwara M. Asakura H. Ductal lesions of exocrine glands and insulitis induced by L3T4+ T cells following graft-versus-host reaction due to major histocompatibility complex class II disparity. Clinical Immunology & Immunopathology. 57(3):339-50, 1990 132. Saitoh T. Fujiwara M. Asakura H. L3T4+ T cells induce hepatic lesions resembling primary biliary cirrhosis in mice with graft-versus-host reactions due to major histocompatibility complex class II disparity. Clinical Immunology & Immunopathology. 59(3):449-61, 1991 133. Saitoh T. Ikarashi Y. Ito S. Watanabe H. Fujiwara M. Asakura H. Depletion of CD8+ cells exacerbates organ-specific autoimmune diseases induced by CD4+ T cells in semiallogeneic hosts with MHC class II disparity. Journal of Immunology. 145(10):3268-75, 1990 134. Sale GE. Buckner CD. Pathology of bone marrow in transplant recipients. Hematology - Oncology Clinics of North America. 2(4):735-56, 1988 135. Salgame P. Abrams JS. Clayberger C. Goldstein H. Convit J. Modlin RL. Bloom BR. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science. 254(5029):279-82, 1991 136. Schiller G. Gale RP. Is there an effective therapy for chronic graft-versus-host disease? Bone Marrow Transplantation. 11(3):189-92, 1993 137. Schraut WH. Current status of small-bowel transplantation. Gastroenterology. 94(2):525-38, 1988 138. Schraut WH. Lee KK. Dawson PJ. Hurst RD. Graft-versus-host disease induced by small bowel allografts. Clinical course and pathology. Transplantation. 41(3):286-90, 1986 139. Schwarer AP. Jiang YZ. Brookes PA. Barrett AJ. Batchelor JR. Goldman JM. Lechler RI. Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone-marrow transplantation. Lancet. 341(8839):203-5, 1993 140. Seemayer TA. Gartner JG. Colle E. Lapp WS. Acute graft-versus-host reaction in the pancreas. Transplantation. 35(1):72-7, 1983 141. Shinozawa T. Beschorner WE. Hess AD. The thymus and prolonged administration of cyclosporine. Irreversible immunopathologic changes associated with autologous pseudo-graft-versus-host disease. Transplantation. 50(1):106-11, 1990 142. Shonnard JW. Davis BK. Nethery L. Cramer DV. In vitro responses of BN strain inbred rats. Transplantation Proceedings. 13(2):1390-3, 1981 143. Shulman HM. Sharma P. Amos D. Fenster LF. McDonald GB. A coded histologic study of hepatic graft-versus-host disease after human bone marrow transplantation. Hepatology. 8(3):463-70, 1988 144. Shulman HM. Sullivan KM. Weiden PL. McDonald GB. Striker GE. Sale GE. Hackman R. Tsoi MS. Storb R. Thomas ED. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. American Journal of Medicine. 69(2):204-17, 1980 145. Siegert W. Josimovic-Alasevic O. Schwerdtfeger R. Baurmann H. Schmidt CA. Musch R. Schmid HJ. Hartmann R. Henze G. Huhn D. et al. Soluble interleukin 2 receptors in patients after bone marrow transplantation. Bone Marrow Transplantation. 6(2):97-101, 1990 146. Siena S. Villa S. Bonadonna G. Bregni M. Gianni AM. Specific ex-vivo depletion of human bone marrow T lymphocytes by an anti-pan-T cell (CD5) ricin A-chain immunotoxin. Transplantation. 43(3):421-6, 1987 147. Sloane JP. Depledge MH. Powles RL. Morgenstern GR. Trickey BS. Dady PJ. Histopathology of the lung after bone marrow transplantation. Journal of Clinical Pathology. 36(5):546-54, 1983 148. Sloane JP. Norton J. The pathology of bone marrow transplantation. Histopathology. 22(3):201-9, 1993 149. Socie G. Selimi F. Sedel L. Frija J. Devergie A. Esperou Bourdeau H. Ribaud P. Gluckman E. Avascular necrosis of bone after allogeneic bone marrow transplantation: clinical findings, incidence and risk factors. British Journal of Haematology. 86(3):624-8, 1994 150. Storb R. Deeg HJ. Whitehead J. Appelbaum F. Beatty P. Bensinger W. Buckner CD. Clift R. Doney K. Farewell V. et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. New England Journal of Medicine. 314(12):729-35, 1986 151. Sullivan KM. Acute and chronic graft-versus-host disease in man. International Journal of Cell Cloning. 4 Suppl 1:42-93, 1986 152. Sullivan KM. Shulman HM. Storb R. Weiden PL. Witherspoon RP. McDonald GB. Schubert MM. Atkinson K. Thomas ED. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood. 57(2):267-76, 1981 153. Sullivan KM. Witherspoon RP. Storb R. Weiden P. Flournoy N. Dahlberg S. Deeg HJ. Sanders JE. Doney KC. Appelbaum FR. et al. Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. Blood. 72(2):546-54, 1988 154. Suzuki M. Suzuki Y. Ikeda H. Koike M. Nomura M. Tamura J. Sato S. Hotta Y. Itoh G. Apoptosis of murine large intestine in acute graft-versus-host disease after allogeneic bone marrow transplantation across minor histocompatibility barriers. Transplantation. 57(8):1284-7, 1994 155. Sviland L. Pearson AD. Green MA. Eastham EJ. Hamilton PJ. Proctor SJ. Malcolm AJ. Prognostic importance of histological and immunopathological assessment of skin and rectal biopsies in patients with GVHD. Bone Marrow Transplantation. 11(3):215-8, 1993 156. Swain SL. Bradley LM. Croft M. Tonkonogy S. Atkins G. Weinberg AD. Duncan DD. Hedrick SM. Dutton RW. Huston G. Helper T-cell subsets: phenotype, function and the role of lymphokines in regulating their development. Immunological Reviews. 123:115-44, 1991 157. Sykes M. Novel approaches to the control of graft versus host disease. Current Opinion in Immunology. 5(5):774-81, 1993 158. Symington FW. Pepe MS. Chen AB. Deliganis A. Serum tumor necrosis factor alpha associated with acute graft-versus-host disease in humans. Transplantation. 50(3):518-21, 1990 159. Tanabe M. Murase N. Demetris AJ. Hoffman RA. Nakamura K. Fujisaki S. Galvao FH. Todo S. Fung J. Starzl TE. The influence of donor and recipient strains in isolated small bowel transplantation in rats. Transplantation Proceedings. 26(6):3733-40, 1994 160. Tatem LD. Hirpara S. Dalsey RM. Iannacone WM. DeLong WG. Hewitt CW. Role of in situ IL-2r and TGF-beta expression in tolerant vascularized bone marrow (limb) transplant chimeras. Transplantation Proceedings. 29(4):2194-5, 1997 161. Thein SL. Goldman JM. Galton DA. Acute "graft-versus-host disease" after autografting for chronic granulocytic leukemia in transformation. Annals of Internal Medicine. 94(2):210-1, 1981 162. Theobald M. Nierle T. Bunjes D. Arnold R. Heimpel H. Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings . New England Journal of Medicine. 327(23):1613-7, 1992 163. Theobald M. Predicting graft-versus-host disease. Current Opinion in Immunology. 7(5):649-55, 1995 164. Thomas E. Storb R. Clift RA. Fefer A. Johnson FL. Neiman PE. Lerner KG. Glucksberg H. Buckner CD. Bone-marrow transplantation (first of two parts). New England Journal of Medicine. 292(16):832-43, 1975 165. Tiley C. Powles R. Teo CP. Treleaven J. Findlay M. Hewetson M. Treatment of acute graft versus host disease with a murine monoclonal antibody to the IL-2 receptor. Bone Marrow Transplantation. 7 Suppl 2:151, 1991 166. Troutt AB. Kelso A. Enumeration of lymphokine mRNA-containing cells in vivo in a murine graft-versus-host reaction using the PCR. Proceedings of the National Academy of Sciences of the United States of America. 89(12):5276-80, 1992 167. Vallera DA. Targeting T cells for GVHD therapy. Seminars in Cancer Biology. 7(2):57-64, 1996 168. van Els CA. D''Amaro J. Pool J. Blokland E. Bakker A. van Elsen PJ. van Rood JJ. Goulmy E. Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance. Immunogenetics. 35(3):161-5, 1992 169. Via CS. Sharrow SO. Shearer GM. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease. Journal of Immunology. 139(6):1840-9, 1987 170. Via CS. Shearer GM. T-cell interactions in autoimmunity: insights from a murine model of graft-versus-host disease. Immunology Today. 9(7-8):207-13, 1988 171. Vogelsang GB. Acute and chronic graft-versus-host disease. Current Opinion in Oncology. 5(2):276-81, 1993 172. Vogelsang GB. Hess AD. Berkman AW. Tutschka PJ. Farmer ER. Converse PJ. Santos GW. An in vitro predictive test for graft versus host disease in patients with genotypic HLA-identical bone marrow transplants. New England Journal of Medicine. 313(11):645-50, 1985 173. Vogelsang GB. Hess AD. Graft-versus-host disease: new directions for a persistent problem. Blood. 84(7):2061-7, 1994 174. Vogelsang GB. Hess AD. Santos GW. Acute graft-versus-host disease: clinical characteristics in the cyclosporine era. Medicine. 67(3):163-74, 1988 175. von Fliedner V. Higby DJ. Kim U. Graft-versus-host reaction following blood product transfusion. American Journal of Medicine. 72(6):951-61, 1982 176. Wagner FF. Flegel WA. Transfusion-associated graft-versus-host disease: risk due to homozygous HLA haplotypes. Transfusion. 35(4):284-91, 1995 177. Wagner JE Jr. Vogelsang GB. Beschorner WE. Pathogenesis and pathology of graft-vs.-host disease. American Journal of Pediatric Hematology-Oncology. 11(2):196-212, 1989 178. Washington K. Gossage DL. Gottfried MR. Pathology of the pancreas in severe combined immunodeficiency and DiGeorge syndrome: acute graft-versus-host disease and unusual viral infections. Human Pathology. 25(9):908-14, 1994 179. Weisdorf D. Filipovich A. McGlave P. Ramsay N. Kersey J. Miller W. Blazar B. Combination graft-versus-host disease prophylaxis using immunotoxin (anti-CD5-RTA [Xomazyme-CD5]) plus methotrexate and cyclosporine or prednisone after unrelated donor marrow transplantation. Bone Marrow Transplantation. 12(5):531-6, 1993 180. Wingard JR. Santos GW. Saral R. Late-onset interstitial pneumonia following allogeneic bone marrow transplantation. Transplantation. 39(1):21-3, 1985 181. Woolley DS. Hou A. Strande L. Tatem L. Mathews M. Hewitt CW. Vascularized bone marrow transplantation and graft versus host disease: morphometric analysis of muscle. Transplantation Proceedings. 26(6):3321-2, 1994 182. Workman DL. Clancy J Jr. Interstitial pneumonitis and lymphocytic bronchiolitis/bronchitis as a direct result of acute lethal graft-versus-host disease duplicate the histopathology of lung allograft rejection. Transplantation. 58(2):207-13, 1994 183. Wu M. Enhancement of immunotoxin activity using chemical and biological reagents. British Journal of Cancer. 75(9):1347-55, 1997 184. Wyatt SE. Nunn P. Hows JM. Yin J. Hayes MC. Catovsky D. Gordon-Smith EC. Hughes JM. Goldman JM. Galton D. Airways obstruction associated with graft versus host disease after bone marrow transplantation. Thorax. 39(12):887-94, 1984 185. Xun CQ. Thompson JS. Jennings CD. Brown SA. Widmer MB. Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice. Blood. 83(8):2360-7, 1994 186. Yasuda H. Ohto H. Abe R. Mechanism of transfusion-associated graft-versus-host disease. Fukushima Journal of Medical Science. 39(2):69-75, 1993 187. Yeh LS. Gregory CR. Griffey SM. Lecouter RA. Hou SM. Morris RE. Combination leflunomide and cyclosporine prevents rejection of functional whole limb allografts in the rat. Transplantation. 64(6):919-22, 1997 188. Zeis M. Uharek L. Glass B. Steinmann J. Dreger P. Gassmann W. Schmitz N. Allogeneic MHC-mismatched activated natural killer cells administered after bone marrow transplantation provide a strong graft-versus-leukaemia effect in mice. British Journal of Haematology. 96(4):757-61, 1997 189. Zhong R. He G. Sakai Y. Zhang Z. Garcia B. Li XC. Jevnikar A. Grant D. The effect of donor-recipient strain combination on rejection and graft-versus-host disease after small bowel/liver transplantation in the rat. Transplantation. 56(2):381-5, 1993
|